Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 110 Head and Neck Neoplasms 97 Nasopharyngeal Carcinoma 36 Carcinoma, Non-Small-Cell Lung 21 Salivary Gland Neoplasms 17 Carcinoma, Squamous Cell 14 Laryngeal Neoplasms 12 Nasopharyngeal Neoplasms 10 Melanoma 10 Breast Neoplasms 10 Oropharyngeal Neoplasms 9 Hypopharyngeal Neoplasms 9 Stomach Neoplasms 8 Neoplasms 8 Esthesioneuroblastoma, Olfactory 8 Esophageal Neoplasms 8 Prostatic Neoplasms 7 Ovarian Neoplasms 7 Carcinoma, Renal Cell 7 Urinary Bladder Neoplasms 6 Tongue Neoplasms 6 Small Cell Lung Carcinoma 6 Recurrence 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Thyroid Neoplasms 4 Mouth Neoplasms 4

Interventions

Cisplatin 2 motexafin gadolinium 1 Standard of Care 1 Radiation 1 Practice Guidelines as Topic 1 Erlotinib Hydrochloride 1 Docetaxel 1 Chemoradiotherapy 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Tonsillar Neoplasms × Docetaxel × Head & Neck × Clear all

NCT04277858 2023-10-23

NECTORS

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Recruiting

Oropharyngeal Neoplasms, Tonsillar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡